Virtu Financial LLC Unity Biotechnology, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.4 - $4.27 $11,016 - $117,604	-27,542 Reduced 43.97%	35,098 $14,000
Q2 2022 Aug 09, 2022	BUY	$0.56 - $1.29 $7,101 - $16,358	12,681 Added 25.38%	62,640 $35,000
Q1 2022 May 17, 2022	SELL	$0.72 - $1.86 $2,411 - $6,229	-3,349 Reduced 6.28%	49,959 $56,000
Q4 2021 Feb 17, 2022	BUY	$1.3 - $3.17 $69,300 - $168,986	53,308 New	53,308 $78,000
Q4 2020 Feb 24, 2021	SELL	$3.42 - $6.36 $176,865 - $328,907	-51,715 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$2.94 - $12.43 $152,042 - $642,817	51,715 New	51,715 $179,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.